Target intelligence / Profile preview

SLC14A2 antisense RNA 1 (SLC14A2-AS1)

Target
SLC14A2-AS1
Molecular classification
Antisense long non-coding RNA, lncRNA
01

Overview

SLC14A2 antisense RNA 1 (SLC14A2-AS1) is an antisense long non-coding RNA transcribed from the opposite strand of the SLC14A2 (solute carrier family 14 member 2) gene. While many antisense lncRNAs are known to regulate the expression of their corresponding sense genes through diverse mechanisms—including chromatin modification, transcriptional interference, and mRNA stability—there are currently no detailed studies specifically characterizing the function, disease associations, or therapeutic relevance of SLC14A2-AS1 itself. In general, antisense lncRNAs can modulate cellular processes such as proliferation, migration, invasion, and responsiveness to therapy, often in a cancer context[2]. However, SLC14A2-AS1 is not presently recognized as a therapeutic target, nor are there known drugs, biomarkers, or specific disease roles documented for this molecule. The SLC14A2 gene encodes a urea transporter and is a member of the solute carrier (SLC) family[1][4]. However, SLC14A2-AS1 is distinct from the protein-coding SLC14A2 gene and encodes a regulatory RNA rather than a protein. There are many other antisense lncRNAs (such as FOXP4-AS1, HAND2-AS1) with documented roles in cancer and as potential therapeutic targets[2], but no functional or therapeutic data regarding SLC14A2-AS1 specifically are currently available in the public domain.

Other names
SLC14A2-AS1
02

Biological functions

Regulation of gene expressionModulation of SLC14A2 mRNA expressionModulation of SLC14A2 mRNA stability

Beyond the preview

Go deeper on SLC14A2 antisense RNA 1 (SLC14A2-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SLC14A2 antisense RNA 1 (SLC14A2-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call